Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 849 results for "gilead sciences"

Gilead Sciences to Release Third Quarter 2014 Financial Results on Tuesday, October 28, 2014
Securities Technology Monitor

Earnings Expected to Increase for Gilead Sciences

Optimism surrounds Gilead Sciences , as it gets ready to report its third quarter results on Tuesday, October 28, 2014. Analysts are expecting the company to book a profit of $1.64 a share, up from 50 cents a year ago. The consensus estimate is ..., 22 hours ago

39 images for gilead sciences

American Banking News, 17 hours ago
AdvisorOne, 19 hours ago
RIA Novosti, 2 weeks ago
Stockhouse Bulletin Boards, 1 week ago
BusinessWeek, 1 week ago
Chicago Daily Herald, 2 weeks ago
Jutia Group, 2 weeks ago
Value Walk, 3 weeks ago
Yale University, 1 day ago
Schaeffers Research, 22 hours ago

Gilead Stock Will Rise on SovaldiĀ® Sales

Popular Posts: Recent Posts: Gilead Sciences ( GILD ) is a researched based biopharmaceutical company focused on developing treatments for human immunodeficiency virus (HIV), liver diseases such as chronic hepatitis B virus (HBV) infection and ...
 InvestorPlace.com1 day ago Stocks Cap Week With Solid Gains; Gilead Clears Buy Point  Investor's Business Daily19 hours ago Stock Market Today: Stocks Snap Four-Week Slide  Investor's Business Daily15 hours ago Trading could get scary next week  CNBC16 hours ago

Will Gilead (GILD) Miss Earnings on High Operating Costs?

Gilead Sciences, Inc. ( GILD ) is set to report third-quarter 2014 results on Oct 28 after the market closes. Last quarter, the company delivered a positive earnings surprise of 44.10%. Let's see how things are shaping up for this announcement. ...
 Yahoo! Finance20 hours ago
American Banking News

Gilead Sciences Hits New 12-Month High at $111.47 (GILD)

Shares of Gilead Sciences (NASDAQ:GILD) reached a new 52-week high during mid-day trading on Friday , reports. The stock traded as high as $111.47 and last traded at $110.06, with a volume of 9,627,668 shares traded. The ...
 American Banking News17 hours ago Watch for Shares of Gilead Sciences (GILD) to Approach Resistance at $104.98  Individual.com4 days ago Gilead Sciences (GILD) Approaches New Upside Target of $104.98  Individual.com4 days ago Shares of Gilead Sciences Receive a Boost, Up 4.8%  Individual.com1 week ago
Pharma Letter

Gilead Sciences : FDA Approvides Harvoni (Ledipasvir/Sofosbuvir)

Gilead Sciences recently reported that the U.S. Food and Drug Administration (FDA) has approved Harvoni (ledipasvir 90 mg/ sofosbuvir 400 mg), a once-daily single tablet regimen for the treatment of chronic hepatitis C genotype 1 infection in ...
 4 Traders10 hours ago Harvoni will keep Gilead atop Hepatitis C virus treatment landscape, says GlobalData Analyst  European Pharmaceutical Review3 days ago Gilead: FDA Approvides Harvoni (Ledipasvir/Sofosbuvir) [Professional Services Close - Up]  Pharmacy Choice4 hours ago GlobalData Analyst: Harvoni Will Keep Gilead Atop Hepatitis C Virus Treatment Landscape  PharmaceuticalProcessing2 days ago

GILEAD SCIENCES : Watchers Looking for Commentary on New Drug's Launch -- Earnings Preview

By Jonathan D. Rockoff Gilead Sciences Inc. is scheduled to report earnings Tuesday afternoon. Here's what you need to know. EARNINGS FORECAST: Net income of $1.92 is the consensus of analysts surveyed by Thomson Reuters, compared with 52 ...
 4 Traders19 hours ago Gilead Watchers Looking for Commentary on New ...  ADVFN UK18 hours ago

AHF To Gilead Sciences, Inc.: Do Your Patriotic Duty And Lower Hep. C Drug Prices For Veterans

WASHINGTON--(BUSINESS WIRE)--AIDS Healthcare Foundation (AHF), the world's largest AIDS organization and an outspoken advocate against runaway drug pricing for lifesaving HIV/AIDS and other medications, today called on Gilead Sciences, Inc., the ...
 BioSpace21 hours ago AHF to Gilead: Do Your Patriotic Duty and Lower Hep. C Drug Prices for Veterans  Pettinga Financial Advisors1 day ago AHF TO GILEAD : Do Your Patriotic Duty and Lower Hep. C Drug Prices for Veterans  4 Traders1 day ago

Gilead Sciences, Vipshop Set Up Base Patterns

Now that the market is back in an uptrend, investors should look to buy stocks breaking out from bases. Gilead Sciences and Vipshop Holdings haven't broken out yet, but they are clearly two leaders in bases. Gilead Sciences (NASDAQ: GILD ) is in ...
 Investor's Business Daily1 day ago

Gilead Q3 Earnings Preview: Sovaldi Drives Another Brilliant Quarter

Gilead Sciences is expected to report upbeat earnings for the third quarter on Oct. 28, as it witnesses another high-growth quarter on the back of Sovaldi's sales Page 1 of 2 Click Ticker to See live coverage Gilead Sciences, Inc. ( ...
 Bidness Etc2 days ago Q3 Earnings: Weak Growth & Guidance  Zacks.com19 hours ago

Gilead Sciences: Pricing, Politics And Profits

Summary The political flack over Gilead's HVC pricing continues. Pricing concerns are overblown. As a best in class market leader, Gilead will dominate and shares will eclipse $150 within 12 months. The other day I was rifling through the ...
 Seeking Alpha3 days ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Related Queries - gilead sciences
Get updated on latest news & your favorite topics right in your inbox!
More     Less